Aurinia Pharmaceuticals Inc. (AUPH) earnings date, results and what the price requires

    Nasdaq · SEC CIK 0001600620 · SEC filings checked Oct 18, 2026

    Next report
    Nov 10, 2026
    Estimated from reporting history (96-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
    Last close
    $16.51
    Polygon.io daily close, Oct 16, 2026. End of day, not live.
    Trailing diluted EPS
    $2.29
    Sum of quarters ending Jun 30, 2026, Mar 31, 2026, Dec 31, 2025, Sep 30, 2025 · P/E 7.2

    Previous results (SEC filings)

    Quarter endedReportedRevenueNet incomeDiluted EPSSource
    Jun 30, 2026Aug 6, 2026$83.2M$37.4M$0.28Filing
    Mar 31, 2026May 7, 2026$77.7M$34.4M$0.25Filing
    Dec 31, 2025Feb 26, 2026$77.1M$210.8M$1.53Filing
    Sep 30, 2025Nov 4, 2025$73.5M$31.6M$0.23Filing
    Jun 30, 2025Jul 31, 2025$70.0M$21.5M$0.16Filing
    Mar 31, 2025May 12, 2025$62.5M$23.3M$0.16Filing
    Dec 31, 2024Feb 27, 2025$59.9M$1.4M$0.01Filing
    Sep 30, 2024Nov 7, 2024$67.8M$14.3M$0.10Filing

    What would Aurinia Pharmaceuticals Inc. have to report for its valuation to change?

    At $16.51, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -9.2% a year, to $1.41. On that path the next quarter needs diluted EPS near $0.21, against $0.23 in the quarter ended Sep 30, 2025.

    Are you considering buying, or do you already own shares?

    Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.

    ResultOriginalYours
    Required EPS growth / year-9.2%-9.2%
    EPS needed in final year$1.41$1.41

    Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.

    Prepare for earnings across my investments — $399/month

    Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. AUPH goes in with your buy-or-wait comparison and assumptions preserved.

    Start Desk — $399/month

    Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.